Healthcare and pharma stocks: prices, earnings and filings
Drugmakers, obesity-drug leaders and insurers. 5 stocks, updated 8:07 AM ET 16 Oct.
The 5 Healthcare and pharma stocks tracked here are worth a combined $2.0T, based on Nasdaq market values. In Thursday's session 5 of 5 closed higher and the average move was +2.99%; Eli Lilly (LLY) did best at +3.55% and Novartis (NVS) worst at +2.38%.
This year the leader is UnitedHealth (UNH), up 23.2%, while Ionis Pharmaceuticals (IONS) is down 44.2%. Next to report is Novartis on Tuesday 27 October.
Fastest revenue growth in the latest reported quarter: Eli Lilly +47.7% to $23.0B, UnitedHealth +0.4% to $112.0B, Ionis Pharmaceuticals -40.7% to $267.9M (SEC filings).
| Stock | Last | Day | 1M | YTD | Mkt cap | Revenue (last Q, YoY) | Next earnings |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly | $1,251.61 | +3.55% | +10.0% | +16.5% | $1.2T | $23.0B +47.7% | 29 Oct |
| UNH UnitedHealth | $406.67 as of 4:00 PM ET Thu 15 Oct | +2.79% | +8.4% | +23.2% | $365.0B | $112.0B +0.4% | – |
| NVS Novartis | $150.38 as of 4:00 PM ET Thu 15 Oct | +2.38% | +8.4% | +9.1% | $286.9B | – | 27 Oct |
| NVO Novo Nordisk | $39.22 as of 4:00 PM ET Thu 15 Oct | +2.89% | -6.0% | -22.9% | $173.7B | $309.1B +6.4% | 4 Nov* |
| IONS Ionis Pharmaceuticals | $44.12 as of 4:00 PM ET Thu 15 Oct | +3.33% | -1.6% | -44.2% | $7.2B | $267.9M -40.7% | 4 Nov* |
* estimated date (Zacks via Nasdaq). Revenue from SEC filings; annual for foreign filers that report yearly.
Year to date
Stories on these stocks
More stock lists
The daily filings brief
Before the US open: the movers, the SEC filings and the earnings that matter. Free, one short email per US trading day.
We only use your email to send the brief.